# A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)

> **NCT00420589** · PHASE3 · TERMINATED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1000 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** taranabant
- **DRUG:** Comparator: placebo

## Key facts

- **NCT ID:** NCT00420589
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2008-02
- **Final completion:** 2008-11
- **Target enrollment:** 1000 (ACTUAL)
- **Why stopped:** The overall profile does not support development for obesity
- **Last updated:** 2015-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420589, "A Weight Maintenance Study in Obese Patients (0364-012)(TERMINATED)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00420589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*